The purpose of this study is to determinate the effect of a pre-treatment with bupropion, a
dopamine and norepinephrine transporter inhibitor, on the pharmacodynamics and
pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). The study will
provide further understanding of the dopaminergic regulation of mood.